PET imaging of hepatocellular carcinoma with 2-deoxy-2[18F]fluoro-D-glucose, 6-deoxy-6[18F]fluoro-D-glucose, [1-11C]-acetate and [N-methyl-11C]-choline

被引:0
|
作者
Salem, N. [2 ]
Kuang, Y. [2 ]
Wang, F. [2 ]
MacLennan, G. T. [3 ]
Lee, Z. [1 ,2 ]
机构
[1] Univ Hosp Case Med Ctr, Dept Radiol, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA
[3] Univ Hosp Case Med Ctr, Dept Pathol, Cleveland, OH 44106 USA
关键词
Fluorodeoxyglucose F18; Tomography; emission computed; Acetates; Choline; Carcinoma; hepatocellular; molecular imaging; POSITRON-EMISSION-TOMOGRAPHY; ACETYL-COA SYNTHETASE; GLUCOSE-TRANSPORT; PROSTATE-CANCER; SKELETAL-MUSCLE; FDG-PET; IN-VIVO; METABOLISM; CHOLINE; ACETATE;
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Aim This study was designed to investigate the performance of positron emission tomography (PET) imaging for hepatocellular carcinoma (HCC) on a hepatitis viral infection-induced woodchuck model using existing tracers such as 2-deoxy-2[F-18]fluoro-D-glucose (2FDG), 6-deoxy-6[F-18]fluoro-D-glucose (6FDG), [1-C-11]acetate (acetate) and [N-methyl-C-11]choline (choline). Methods. Fourteen woodchucks with HCC were imaged with different radiotracers: 13 (10 with HCC and 3 controls) with 2FDG; 4 (3 with HCC and I control) with 6FDG; 13 (10 with HCC and 3 controls) with acetate; 4 (2 with HCC and 2 controls) with choline. The woodchucks were euthanized after imaging experiments and liver tissues were harvested for histology, for enzymatic activities including hexokinase (HK), glucose-6-phosphatase, acetyl-CoA synthetase (ACAS) and choline kinase (CK), and for differential gene expressions between the HCCs and the surrounding hepatic tissues. Results. 2FDG detected 7/13 tumors with a tumor-to-liver uptake ratio (T/L) of 1.36 +/- 0.13. Five of these HCCs were moderately- or poorly-differentiated. The HK/glucose-6-phosphatase ratio was significantly higher in HCCs compared to the surrounding liver tissues (P=0.05). None of the HCCs imaged with 6FDG were detected by PET (T/L=1.01 +/- 0.11). Acetate detected 16/17 HCCs (T/L=2.02 +/- 0.7). ACAS activity was significantly higher in HCCs (P=0.01) and lipids-related genes were found upregulated. Choline imaging detected all HCCs (T/L=1.63 +/- 0.34). CK activity was significantly higher in HCCs (P=0.001). Conclusion. Well-differentiated and some moderately-differentiated HCCs do not uptake 2FDG more than the surrounding liver tissues, but display increased acetate uptake. There is no contrast between HCCs and the surrounding liver tissues on the 6FDG PET images. Despite elevated background signal from the liver, choline uptake seems to be detectable in the HCCs scanned in this study.
引用
收藏
页码:144 / 156
页数:13
相关论文
共 50 条
  • [31] Differences in Transport Mechanisms of trans-1-Amino-3-[18F]Fluorocyclobutanecarboxylic Acid in Inflammation, Prostate Cancer, and Glioma Cells: Comparison with L-[Methyl-11C]Methionine and 2-Deoxy-2-[18F]Fluoro-D-Glucose
    Oka, Shuntaro
    Okudaira, Hiroyuki
    Ono, Masahiro
    Schuster, David M.
    Goodman, Mark M.
    Kawai, Keiichi
    Shirakami, Yoshifumi
    MOLECULAR IMAGING AND BIOLOGY, 2014, 16 (03) : 322 - 329
  • [32] Pulmonary 2-deoxy-2-[18F]-fluoro-D-glucose uptake is low in treated patients with idiopathic pulmonary arterial hypertension
    Ruiter, Gerrina
    Wong, Yeun Ying
    Raijmakers, Pieter
    Huisman, Marc C.
    Lammertsma, Adriaan A.
    Knaapen, Paul
    de Man, Frances S.
    Westerhof, Nico
    van der Laarse, Willem J.
    Vonk-Noordegraaf, Anton
    PULMONARY CIRCULATION, 2013, 3 (03) : 647 - 653
  • [33] Impact of 2-deoxy-2[F-18]fluoro-D-glucose positron emission tomography on the management of patients with advanced melanoma
    Harris, MT
    Berlangieri, SU
    Cebon, JS
    Davis, ID
    Scott, AM
    MOLECULAR IMAGING AND BIOLOGY, 2005, 7 (04) : 304 - 308
  • [34] Dual time point 2-deoxy-2-[18F]fluoro-D-glucose PET/CT: Nodal staging in locally advanced breast cancer
    Garcia Vicente, A. M.
    Soriano Castrejon, A.
    Cruz Mora, M. A.
    Ortega Ruiperez, C.
    Espinosa Aunion, R.
    Leon Martin, A.
    Gonzalez Ageitos, A.
    Van Gomez Lopez, O.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2014, 33 (01): : 1 - 5
  • [35] Impact of 2-Deoxy-2[F-18]Fluoro-d-Glucose Positron Emission Tomography on the Management of Patients with Advanced Melanoma
    Marion T. Harris
    Salvatore U. Berlangieri
    Jonathan S. Cebon
    Ian D. Davis
    Andrew M. Scott
    Molecular Imaging and Biology, 2005, 7 : 304 - 308
  • [36] Differentiation of benign vs. malignant mass in a postirradiation cerebral arteriovenous malformation by 2-deoxy-2[18F] fluoro-D-glucose positron emission tomography
    Raman, A
    Rothrock, JF
    Liu, HG
    Mountz, JM
    MOLECULAR IMAGING AND BIOLOGY, 2004, 6 (01) : 1 - 6
  • [37] Ferret Thoracic Anatomy by 2-Deoxy-2-(18F)Fluoro-D-Glucose (18F-FDG) Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) Imaging
    Wu, Albert
    Zheng, Huaiyu
    Kraenzle, Jennifer
    Biller, Ashley
    Vanover, Carol D.
    Proctor, Mary
    Sherwood, Leslie
    Steffen, Marlene
    Ng, Chin
    Mollura, Daniel J.
    Jonsson, Colleen B.
    ILAR JOURNAL, 2012, 53 (01) : E9 - +
  • [38] Assessing Lung Inflammation After Nanoparticle Inhalation Using 2-deoxy-2-[18F]fluoro-d-glucose Positron Emission Tomography Imaging
    Carlos Pérez-Campaña
    Vanessa Gómez-Vallejo
    Maria Puigivila
    Abraham Martin
    Teresa Calvo-Fernández
    Sergio E. Moya
    Søren Thor Larsen
    Juan D. Gispert
    Jordi Llop
    Molecular Imaging and Biology, 2014, 16 : 264 - 273
  • [39] The diagnosis of esophageal cancer by 2-deoxy-2-F-18 fluoro-D-glucose positron emission tomography (F-18 FDG PET)
    Alexander, Mohab
    Brasic, James Robert
    CLINICAL NUCLEAR MEDICINE, 2006, 31 (09) : 566 - 567
  • [40] Comparison of: (2S,4R)-4-[18F]Fluoroglutamine, [11C]Methionine, and 2-Deoxy-2-[18F]Fluoro-D-Glucose and Two Small-Animal PET/CT Systems Imaging Rat Gliomas
    Miner, Maxwell W. G.
    Liljenback, Heidi
    Virta, Jenni
    Helin, Semi
    Eskola, Olli
    Elo, Petri
    Teuho, Jarmo
    Seppala, Kerttu
    Oikonen, Vesa
    Yang, Guangli
    Kindler-Roehrborn, Andrea
    Minn, Heikki
    Li, Xiang-Guo
    Roivainen, Anne
    FRONTIERS IN ONCOLOGY, 2021, 11